Cargando…
Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma
HER-3 expression has been reported to act as an important oncoprotein in head and neck squamous cell carcinoma. This protein is known to control tumor proliferation and acquisition of resistance by tumor cells towards EGFR inhibitors, therefore, development of a HER-3-targeted therapy is desirable....
Autores principales: | Kumai, Takumi, Ohkuri, Takayuki, Nagato, Toshihiro, Matsuda, Yoshinari, Oikawa, Kensuke, Aoki, Naoko, Kimura, Shoji, Celis, Esteban, Harabuchi, Yasuaki, Kobayashi, Hiroya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633732/ https://www.ncbi.nlm.nih.gov/pubmed/26538233 http://dx.doi.org/10.1038/srep16280 |
Ejemplares similares
-
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
por: Hirata-Nozaki, Yui, et al.
Publicado: (2019) -
Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor
por: Kumai, Takumi, et al.
Publicado: (2014) -
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
por: Hayashi, Ryusuke, et al.
Publicado: (2020) -
EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy
por: Kumai, T, et al.
Publicado: (2013) -
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
por: Kosaka, Akemi, et al.
Publicado: (2021)